On Monday, Inovio Pharmaceuticals Inc (NASDAQ: INO) opened lower -7.33% from the last session, before settling in for the closing price of $2.32. Price fluctuations for INO have ranged from $2.14 to $14.75 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 60.80% annually for the last half of the decade. Company’s average yearly earnings per share was noted 28.41% at the time writing. With a float of $25.80 million, this company’s outstanding shares have now reached $26.05 million.
In an organization with 122 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -767.0%, operating margin of -58709.67%, and the pretax margin is -12414736.82%.
Inovio Pharmaceuticals Inc (INO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Inovio Pharmaceuticals Inc is 1.14%, while institutional ownership is 33.07%.
Inovio Pharmaceuticals Inc (INO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 28.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.50% during the next five years compared to 13.49% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
Check out the current performance indicators for Inovio Pharmaceuticals Inc (INO). In the past quarter, the stock posted a quick ratio of 3.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 173.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.48, a number that is poised to hit -0.92 in the next quarter and is forecasted to reach -3.46 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Let’s dig in a bit further. During the last 5-days, its volume was 3.02 million. That was better than the volume of 0.46 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 5.16%. Additionally, its Average True Range was 0.35.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 1.12%, which indicates a significant decrease from 4.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 197.40% in the past 14 days, which was higher than the 91.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.85, while its 200-day Moving Average is $8.34. However, in the short run, Inovio Pharmaceuticals Inc’s stock first resistance to watch stands at $2.36. Second resistance stands at $2.56. The third major resistance level sits at $2.72. If the price goes on to break the first support level at $1.99, it is likely to go to the next support level at $1.83. Assuming the price breaks the second support level, the third support level stands at $1.63.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
There are currently 26,100K shares outstanding in the company with a market cap of 34.62 million. Presently, the company’s annual sales total 830 K according to its annual income of -135,120 K. Last quarter, the company’s sales amounted to 100 K and its income totaled -32,240 K.
